Hematologic Adverse Effects of Aminoglutethimide

    loading  Checking for direct PDF access through Ovid

Abstract

To the editor: Aminoglutethimide has been increasingly used in the treatment of hormonally responsive breast cancer instead of surgical adrenalectomy or hypophysectomy. The common side effects of the drug include skin rash and central-nervous-system side effects (lethargy, ataxia, and dizziness). These side effects are usually transient and rarely require discontinuation of the therapy. Hematotoxicity has been reported in few patients (1, 2), but the magnitude of this side effect has been emphasized in earlier publications. We would like to report our experience with three patients who developed severe, unexcepted, hematologic complications during treatment with aminoglutethimide. At our institution, 163 patients

Related Topics

    loading  Loading Related Articles